Thermo Fisher Scientific Snags Brahms For $470M

Law360, New York (September 3, 2009, 4:03 PM EDT) -- Thermo Fisher Scientific Inc. has inked an agreement to purchase Brahms AG, Germany's third-largest biotechnology company, in a $470 million share purchase deal.

The deal, which is still subject to regulatory approval, is expected to close in late September, both companies said in announcements Wednesday.

Thermo Fisher will buy 100 percent of Brahms Holding GmbH's capital, including debt and other liabilities, from Brahms' joint owners — management and private equity investors — Brahms said.

Thermo Fisher, based in Waltham, Mass., will integrate Brahms into its $1.3...
To view the full article, register now.